EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ferrocenyl β‐Diketonate Compounds: Extended Ring Systems for Improved Anticancer Activity

Benjamin J Hofmann iD, Enas T Aljohani, Natalia Cicovacki, Ivan Lee, Derek T Warren iD, Anastasia Sobolewski iD, Tameryn Stringer iD, Rianne M Lord iD

ChemBioChem · 2025

DOI: 10.1002/cbic.202400759 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemBioChem, 2025. Verfasst von Benjamin J Hofmann und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, Pharmacy and Pharmacology, University of East Anglia, Norwich, Norfolk, NR4 7TJ, UK. Hauptthemen laut MEDLINE: Ferrous Compounds, Antineoplastic Agents, Ketones. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Majmaah University, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A library of ferrocenyl β‐diketonate compounds with varying degrees of aromatic functionality have been synthesized and fully characterized. This includes cyclic voltammetry and the analysis of four new structures by single crystal X‐ray diffraction. The compounds cytotoxic potential has been determined by MTT screening against pancreatic carcinoma (MIA PaCa‐2), ovarian adenocarcinoma (A2780), breast adenocarcinomas (MDA‐MB‐231 and MCF‐7) and normal epithelial retinal (ARPE‐19). The compounds show a general trend, where increasing the number of aromatic rings in the molecule yields an increase in cytotoxicity and follows the trend anthracenyl>naphthyl>phenyl>methyl. The compounds are particularly sensitive to the triple negative cancer cell line MDA‐MB‐231, and the potential modes of action have been studied by production of reactive oxygen species using fluorescence microscopy and cell morphology using Scanning Electron Microscopy. All assays highlight the ferrocenyl β‐diketonate with an anthracenyl substituent to be the lead compound in this library. The decomposition of this compound was also observed within cells, yielding a cytotoxic fluorescent molecule, which has been visualized by confocal microscopy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ferrous CompoundsAntineoplastic AgentsKetonesHumansCell Line, TumorDrug Screening Assays, AntitumorReactive Oxygen SpeciesMetallocenesStructure-Activity RelationshipMolecular StructureCrystallography, X-RayCell ProliferationCell Survival

Stichwörter der Autor:innen

AcetylacetoneAnticancerBioinorganicFerrocenylFluorescence

Substanzen

Ferrous CompoundsAntineoplastic AgentsReactive Oxygen SpeciesMetallocenesKetones

Autor:innen und Institutionen

  • School of Chemistry, Pharmacy and Pharmacology, University of East Anglia, Norwich, Norfolk, NR4 7TJ, UK.
  • Department of Chemistry, University of Warwick, Coventry, CV4 7SH, UK.
  • School of Chemistry, University of Waikato, Hamilton, 3240, New Zealand.

ORCID-Profile: Benjamin J Hofmann, Derek T Warren, Anastasia Sobolewski, Tameryn Stringer, Rianne M Lord

Förderung

  • Majmaah University
  • Medical Research Council

Zitieren

APA

Hofmann, B. J., Aljohani, E. T., Cicovacki, N., Lee, I., Warren, D. T., Sobolewski, A., Stringer, T., & Lord, R. M. (2025). Ferrocenyl β‐Diketonate Compounds: Extended Ring Systems for Improved Anticancer Activity. ChemBioChem. https://doi.org/10.1002/cbic.202400759

Vancouver

Hofmann BJ, Aljohani ET, Cicovacki N, Lee I, Warren DT, Sobolewski A, et al. Ferrocenyl β‐Diketonate Compounds: Extended Ring Systems for Improved Anticancer Activity. ChemBioChem. 2025. doi:10.1002/cbic.202400759

BibTeX
@article{Hofmann2025,
  author = {Hofmann, Benjamin J and Aljohani, Enas T and Cicovacki, Natalia and Lee, Ivan and Warren, Derek T and Sobolewski, Anastasia and Stringer, Tameryn and Lord, Rianne M},
  title = {Ferrocenyl β‐Diketonate Compounds: Extended Ring Systems for Improved Anticancer Activity},
  journal = {ChemBioChem},
  year = {2025},
  doi = {10.1002/cbic.202400759}
}
Kostenlos starten →